Insiders Organovo Holdings, Inc.

Equities

ONVO

US68620A2033

Market Closed - Nasdaq Other stock markets 01:30:00 26/06/2024 am IST			5-day change	1st Jan Change
0.75 ^USD	-5.06%		-13.30%	-32.43%

31/05	Organovo Holdings, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024	CI
15/04	Organovo's fatty liver disease drug meets main goal in mid-stage study	RE

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Organovo Holdings, Inc. Appoints vaidehi Joshi to the Board as Class I Director	11/22/11	CI
Organovo Holdings, Inc. Announces the Hiring of Curtis Tyree, PhD, as Sr. Vice President of Strategy and Business Development	18/22/18	CI
Organovo Holdings, Inc. Announces Executive Changes	07/21/07	CI
Organovo Holdings, Inc. Appoints Jonathan Lieber as President, Effective May 13, 2021	14/21/14	CI
Organovo Holdings, Inc. Announces Executive Changes	20/21/20	CI
Organovo Holdings, Inc. Announces Management Changes	17/20/17	CI
Organovo Holdings, Inc. Announces Board Changes	15/20/15	CI
Organovo Holdings, Inc. Announces Management Appointments	16/19/16	CI
Organovo Holdings, Inc. Appoints Carolyn Beaver as New Board Member	20/19/20	CI
Organovo Holdings, Inc. Appoints David Shapiro to the Board	06/18/06	CI
Organovo Holdings, Inc. Announces Resignation of Sharon Presnell as Chief Scientific Officer, Effective December 5, 2018	28/18/28	CI
Organovo Announces Appointment of Steven G. Hughes as Chief Medical Officer	01/18/01	CI
Organovo Holdings, Inc. Announces the Resignation of Eric David as Chief Strategy Officer and Executive Vice President of Preclinical Development, Effective December 12, 2017	01/17/01	CI
Organovo Holdings, Inc. Announces the Resignation of Keith Murphy from the Board of Directors	28/17/28	CI
Organovo Holdings, Inc. Announces Management Changes	12/17/12	CI
Organovo Holdings, Inc. Announces Board Appointments	18/16/18	CI
Organovo Holdings, Inc. Appoints Craig Kussman as Chief Financial Officer, Effective August 22, 2016	02/16/02	CI
Organovo Holdings, Inc. Announces Retirement of Richard Heyman from its Board	08/16/08	CI
Organovo Holdings, Inc. Announces Changes to the Management Team	05/16/05	CI
Organovo Holdings, Inc. Appoints Paul Gallant as General Manager of the in Vitro Tissue Service and Product Business	04/15/04	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Organovo Holdings, Inc.

Equities

ONVO

US68620A2033

Insiders

Filters